Re: Share buy back

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BaNosser

Rank: President [?]

Points: 24217 [?]

Votes: 157 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Share buy back

posted on Sep 27, 2007 11:50PM

"These buybacks are, of course, subject to the Company determining at the time licensing revenue distributions are received that such action is prudent based upon market conditions and sound financial management considerations..."

http://www.ptsc.com/news/press_relea...

So, my opinion is Turley felt the market conditions were such that, with the price where it currently is, immediate repurchasing of shares was/is a prudent use cash on hand.. especially when you can repurchase twice as many shares as you could when repurchasing just a few months ago... The PR IMO was also mostly issued as reassurance to shareholders who have watched the share price sink.. 'Shareholders, hang in there.. we have confidence in an eventual reversal of the recent share price trend, and we are putting our money where our mouths are' As for the lack of inclusion of numbers in the PR.. PTSC has never included numbers in any PR.. perhaps they should.. but it's never been their m.o.